Wissenschaftliche Publikationen

 

 

2017

AUTO-ANTI-LWa MAY MIMIC ANTI-D AT FIRST GLANCE

Y.-L. Song, S. Glaus, S. Sigurdardottir, C. Gassner, B.M. Frey, C. Engström

Swisstransfusion
7.-8. September 2017
Fribourg

   
 

CASE REPORT: RARE ANTIBODY AGAINST HIGH FREQUENGY FY5

Y.-L. Song, C. Engström, A. Komarek, G. Rizzi, N. Trost, P. Peghini, I. Hegemann, S.L. Crottet, C. Gassner, B.M. Frey

Swisstransfusion
7.-8. September 2017
Fribourg

   
 

MNS ANTIGEN MG EXCLUSIVELY APPEARS AS 68C>A MUTANT OF GYPA*02 (N) WITHIN THE ZURICH AREA OF SWITZERLAND

S. Sigurdardottir, S. Meyer, C. Portmann, B.M. Frey, C. Gassner

Swisstransfusion
7.-8. September 2017
Fribourg

   
 

TRANSFUSION IN A RARE CASE OF PARA-BOMBAY PHENOTYPE

C. Engström, S. Meyer, Y.-L. Song, A. Komarek, A. O’Meara, C. Papet, K. Neuenschwander, C. Gassner, B.M. Frey

Swisstransfusion
7.-8. September 2017
Fribourg

   
 

PRÄZISIONSMEDIZIN IN DER TRANSFUSIONSVERSORGUNG

B.M. Frey, C. Engström

Pipette - Swiss Laboratory Medicine

Nr. 4/2017

   
  DER SCHWIERIGE FALL: BEREITSTELLUNG ANTIGEN-KOMPATIBLER ERYTHROZYTENKONZENTRATE BEI EINER SCHWANGEREN SICHELZELLPATIENTIN MIT MULTIPLEN ANTIKÖRPERN

S. Lejon Crottet, C. Engström, Y. Song, M. Jutzi, A. Rovó

Pipette - Swiss Laboratory Medicine

Nr. 4/2017

   
 

RISIKO-ABHÄNGIGES SCREENING VON MALARIA UND CHAGAS IM SCHWEIZERISCHEN BLUTSPENDEDIENST SRK

C. Niederhauser, C. Tinguely, J. Gottschalk

Pipette - Swiss Laboratory Medicine

Nr. 4/2017

   
 

ZUSAMMENARBEIT DER SPITÄLER UND DER BLUTSPENDEDIENSTE IN DER BLUTVERSORGUNG

R. Henschler, J. Thierbach, A. Buser

Pipette - Swiss Laboratory Medicine

Nr. 4/2017

   
 

CURRENT DEVELOPMENTS IN MOBILIZATION OF HEMATOPOIETIC STEM AND PROGENITOR CELLS AND THEIR INTERACTION WITH NICHES IN BONE MARROW

R. Richter, W. Forssmann, R. Henschler

Transfusion Medicine and Hemotherapy

2017;44:151-164

   
 

MOLEKULARE BLUTGRUPPENBESTIMMUNG

C. Gassner

Transfusionsmedizin (Thieme Verlag)

2017;7:87-94

   
 

STEPWISE PARTITIONING OF XP21: A PROFILING METHOD FOR XK DELETIONS CAUSATIVE OF THE MC LEOD SYNDROME

C. Gassner, C. Brönnimann, Y. Merki, M.P. Mattle-Greminger, S. Sigurdardottir, E. Meyer, C. Engström, J.D. O'Sullivan, H.H. Jung, B.M. Frey

TRANSFUSION 2017

doi:10.1111/trf.14172

   
 

ANALYSIS OF PLATELET-DERIVED EXTRACELLULAR VESICLES IN PLATELETPHERESIS CONCENTRATES: A MULTICENTER STUDY

A. Black, E. Orso, R. Kelsch, M. Pereira, J. Kamhieh-Milz, A. Salama, M.B. Fischer, E. Meyer, B.M. Frey, G. Schmitz

TRANSFUSION 2017

doi:10.1111/trf.14109

   
 

HUMAN PLATELET ANTIGEN ANTIBODY INDUCTION IN UNCOMPLICATED PREGNANCY IS ASSOCIATED WITH HLA SENSITIZATION

V.S.A. Reiher, G. Hönger, L. Infanti, J.R. Passweg, I. Hösli, B.M. Frey, C. Gassner, S. Meyer, A.S. Buser, A. Holbro, S. Schaub

TRANSFUSION 2017

doi:10.1111/trf.14053

   
 

MALDI-TOF MS ANALYSIS OF 36 BLOOD GROUP ALLELES AMONG 398 THAI SAMPLES REVEALS REGION-SPECIFIC VARIANTS

P. Jongruamklang, C. Gassner, S. Meyer, B.M. Frey, M.L. Olsson, J. Storry

27th Regional Congress of the ISBT

17-21 June, 2017

Copenhangen, Denmark

   
 

REFERENCE SEQUENCES FOR THE MOST FREQUENT ABO* ALLELES OBSERVED IN THE ZURICH REGION OF SWITZERLAND

M.P. Mattle-Greminger, A-L. Hansen, S. Meyer, S. Sigurdardottir, K. Neuenschwander, N. Trost, Y. Merki, C. Portmann, E. Gourri, J. Gottschalk, B.M. Frey, W. Peter, C. Gassner

27th Regional Congress of the ISBT

17-21 June, 2017

Copenhangen, Denmark

   
 

TRANSFUSION IN A RARE CASE OF PARA-BOMBAY PHENOTYPE

C. Engström, S. Meyer, Y. Song, A. Komarek, A. O'Meara, C. Papet, K. Neuenschwander, C. Gassner, B.M. Frey

27th Regional Congress of the ISBT

17-21 June, 2017

Copenhangen, Denmark

   
 

MNS ANTIGEN MG, ENCODED BY GYPA*11 EXCLUSIVELY APPEARS AS POINT MUTANT OF GYPA*02 (N) WITHIN THE ZURICH AREA OF SWITZERLAND

S. Sigurdardottir, S. Meyer, C. Portmann, B.M. Frey, C. Gassner

27th Regional Congress of the ISBT

17-21 June, 2017

Copenhangen, Denmark

   
 

GENETIC BACKGROUND OF THE RARE YUS AND GERBICH BLOOD GROUP PHENOTYPES: HOMOLOGOUS REGIONS OF THE GYPC GENE CONTRIBUTE TO DELETION ALLELES

E. Gourri, G.A. Denomme, Y. Merki, E.A. Scharberg, C. Vrignaud, B.M. Frey, T. Peyrard, C. Gassner

British Journal of Haematology

2017; doi: 10.1111/bjh.14578

(Epub ahead of print)

   
 

KINDLIN-2 MODULATES THE SURVIVAL, DIFFERENTIATION, AND MIGRATION OF INDUCED PLURIPOTENT CELL-DERIVED MESENCHYMAL STROMAL CELLS

M. Moslem, R. Eggenschwiler, C. Wichmann, R. Buhmann, T. Cantz,  R. Henschler

Stem Cells International

2017;7316354

   
 

HUMAN MESENCHYMAL STROMAL CELLS UNDERGO APOPTOSIS AND FRAGMENTATION AFTER INTRAVENOUS APPLICATION IN IMMUNE-COMPETENT MICE

J. Leibacher, K. Dauber, S. Ehser, V. Brixner, K. Kollar, A. Vogel, G. Spohn, R.Schäfer, E. Seifried, R. Henschler

Cytotherapy

2017, 19:61-74

   
2016

WEST NILE VIRUS PREPAREDNESS PLAN TO ENSURE SAFE BLOOD COMPONENTS IN SWITZERLAND: A RISK-BASED APPROACH

C. Niederhauser, S. Fontana, A. Glauser, C. Steinemann, A. Koller

ISBT Science Series

2016, 0, 1-8

   

 

 

 

QUARANTINE VERSUS PATHOGEN-REDUCED PLASMA-COAGULATION FACTOR CONTENT AND ROTATIONAL THROMBOELASTOMETRY COAGULATION

O.M. Theusinger, D. Goslings, J. Studt, B. Brand-Staufer, B. Seifert, D.R. Spahn, B.M. Frey

TRANSFUSION; 2016


 

   

 

 

 

A CASE OF POSSIBLE CHAGAS TRANSMISSION BY BLOOD TRANSFUSION IN SWITZERLAND

J. Ries, A. Komarek, J. Gottschalk, B. Brand, L. Amsler, M. Jutzi, B.M. Frey

Transfus Med Hemother

2016;43:1–3


 

   

 

 

 

CHIP-BASED DIGITAL PCR: AN ACCURATE AND SENSITIVE METHOD FOR ROUTINE CHIMERISM MONITORING AFTER HEMATOPOIETIC STEM CELL TRANSPLANTATION 

E. Gourri, U. Schanz, B.M. Frey, C. Gassner

DGHO, SGH, OeGHO, SGMO Kongress 2016

14.-18. Oktober 2016

Leipzig

 

   

 

 

 

MICE DEFICIENT IN RAP1A GTP ASE DISPLAY REDUCED ADHESION OF HEMATOPOIETIC AND MESENCHYMAL STROMAL CELLS BUT INTACT HEMATOPOIETIC REPOPULATION POTENTIAL

E. Fleck, S. Goetting, H. Kropshofer, J. Steinmann, A. Dom, B. Ruester, E. Seifried, J. Scheele, R. Henschler

J Stem Cell Res Ther

2016; 6:9

   

 

 

 

CHIP-BASED DIGITAL PCR: AN ACCURATE AND SENSITIVE METHOD FOR ROUTINE CHIMERISM MONITORING AFTER HEMATOPOIETIC STEM CELL TRANSPLANTATION

E. Gourri, U. Schanz, B.M. Frey, C. Gassner

49. Jahreskongress DGTI 2016

7.-10. September 2016

Nürnberg

 

   

 

 

 

A NEW GYPB*04 (164T>G,Phe55Cys) ALLELE WITH A PHENOTYPIC PARTIAL CHARACTER OF SMALL S

C. Engstroem, A. Caesar, S. Meyer, C. Portmann, N. Trost, P. Schwind, B.M.Frey, C. Gassner

49. Jahreskongress DGTI 2016

7.-10. September 2016

Nürnberg

 

   

 

 

 

EX VIVO EXPANSION OF T LYMPHOCYTES INDUCES SUBSTANTIAL ALTERATIONS IN CELL SIZE AND ACTIN-BINDING CYTOSKELETAL PROTEINS

I. Weber, K. Kollar, D. Pollet, R. Henschler

49. Jahreskongress DGTI 2016

7.-10. September 2016

Nürnberg

 

   

 

 

 

DESIGN AND VALIDATION OF A NOVEL SET TO POOL, FILTER AND SPLIT 6 UNITS OR 1500ML OF RECOVERED PLASMA PRIOR TO PATHOGEN INACTIVATION WITH INTERCEPT

D. Goslings, A. Valek, D. Reinert, B.M.Frey

49. Jahreskongress DGTI 2016

7.-10. September 2016

Nürnberg

 

   

 

 

 

RED BLOOD CELL USE IN SWITZERLAND: TRENDS AND DEMOGRAPHIC CHALLENGES

T. Volken, A. Buser, D. Castelli, S. Fontana, B.M. Frey, I. Rueskes-Wolter, A. Sarraj, J.Sigle, J. Thierbach, T. Weingand, B. Mansouri-Taleghani

Blood Transfus

2016
DOI 10.2450/2016.0079-16

   

 

 

 

TOO MANY BLOOD DONORS - RESPONSE BIAS IN THE SWISS HEALTH SURVEY 2012

T. Volken, A. Baenziger, A. Buser, D. Castelli, S. Fontana, B.M. Frey, A. Sarraj, J.Sigle, J. Thierbach, T. Weingand, B. Mansouri-Taleghani

Transfus Med Hemother

2016

   

 

 

 

TISSUE ENGINEERING AND REGENERATIVE MEDICINE - NEW INITIATIVES FOR INDIVIDUAL TREATMENT OFFERS

B.M. Frey, S.M. Zeisberger, S.P. Hoerstrup

Transfus Med Hemother

2016;43:318-319

   
 

STEM CELL FACTORIES - THE REBIRTH OF TISSUE ENGINEERING AND REGENERATIVE MEDICINE

B.M. Frey, S.M. Zeisberger, S.P. Hoerstrup

Transfus Med Hemother

2016;43:244-246

   
 

A NEW GYPB*04(164T>G,PHE55CYS) ALLELE WITH A PHENOTYPIC PARTIAL CHARACTER OF SMALL S

C. Engström, A. Caesar, S. Meyer, C. Portmann, N. Trost, E. Meyer, P. Schwind, B.M. Frey, C. Gassner

Swisstransfusion

25.-26.08.2016

Bern

   
 

IMPROVED HBV DONOR SCREENING: SHOULD CURRENT HEPATITIS B RE-ENTRY PROCEDURE BE REASSESSED?

A. Glauser, J. Gottschalk, K. Hardegger, J. Ries, B.M. Frey

Swisstransfusion

25.-26.08.2016

Bern

   
 

PLATELET-DERIVED EXTRACELLULAR VESICLES IN PLATELET CONCENTRATES

A. Black, E. Orso, R. Kelsch, W. Sibrowski, J. Kamhieh-Milz, A.Salama, M.B. Fischer, E. Mayer, B.M. Frey

Swisstransfusion

25.-26.08.2016

Bern

   
 

MALDI-TOF MS GENOTYPING OF 37,234 SWISS PROVES TWO NEW LUTHERAN ALLELES, BOTH POSITIVE FOR AUB

N. Trost, S. Meyer, C. Vollmert, J. Gottschalk, J. Ries, A. Markovic, L. Infanti, A. Buser, S. Amar El Dusouqui, D. Castelli, T. Weingand, A. Sarraj, M.C. Braisch, J. Thierbach, T. Peyrard, B.M. Frey, C. Gassner

Swisstransfusion

25.-26.08.2016

Bern

   
 

A NOVEL SET TO POOL, FILTER AND SPLIT UP TO 6 UNITS OR 1500ML OF PLASMA PRIOR TO INTERCEPT TREATMENT

D. Goslings, A. Valek, D. Reinert, B.M. Frey

Swisstransfusion

25.-26.08.2016

Bern

   
 

HEMATOPOIETIC STEM CELLS IN REGENERATIVE MEDICINE: ASTRAY OR ON THE PATH?

A.M. Mueller, S. Huppertz, R. Henschler

Transfus Med Hemother

2016;43:247-254

   
 

IMPACT OF DONOR ABH-SECRETOR STATUS IN ABO-MISMATCHED LIVING DONOR KIDNEY TRANSPLANTATION

B. Drexler, A. Holbro, J. Sigle, C. Gassner, B.M. Frey, S. Schaub, P. Amico, A. Plattner, L. Infanti, T. Menter, M.J. Mihatsch, M. Stern, A. Buser, M. Dickenmann

Transfusion

2016;56:2355-2361

   
 

INTERNATIONAL SOCIETY OF BLOOD TRANSFUSION WORKING PARTY ON RED CELL IMMUNOGENETICS AND TERMINOLOGY: REPORT OF THE SEOUL AND LONDON MEETINGS

J.R. Storry, L. Castilho, Q. Chen, G. Daniels, G. Denomme, W.A. Flegel, C. Gassner, M. de Haas, C. Hyland, M. Keller, C. Lomas-Francis, J.M. Moulds, N. Nogues, M.L. Olsson, T. Peyrard, C.E. van der Schoot, Y. Tano, N. Thornton, F. Wagner, S. Wendel, C. Westhoff, V. Yahalom

ISBT Science Series

2016;11:118-122

   
 

MNSS GENOTYPING BY MALDI-TOF MS SHOWS HIGH CONCORDANCE WITH SEROLOGY, ALLOWS GENE COPY NUMBER TESTING AND REVEALS NEW ST(A) ALLELES

S. Meyer, C. Vollmert, N. Trost, C. Portmann, J. Gottschalk, J. Ries, A.  Markovic, L. Infanti, A. Buser, S. Amar El Dusouqui, E. Rigal, D. Castelli, B. Weingand, A. Maier, S.M. Mauvais, A. Sarraj, M.C. Braisch, J. Thierbach, H. Hustinx, B.M. Frey, C. Gassner

British Journal of Hematology 2016;174(4):624-36

 

   
 

MANAGEMENT OF ANTI-COLTONa ALLOIMMUNISATION IN PREGNANCY: A CASE REPORT

N. Kimmich, B. Brand, H. Hustinx, A. Komarek, R. Zimmermann

Transfusion Medicine 2016;26:150-152
   
  SELECTIVE TESTING OF AT-RISK BLOOD DONORS FOR TRYPANOSOMA CRUZI AND PLASMODIUM SPP. IN SWITZERLAND

C. Niederhauser, J. Gottschalk, C. Tinguely

Transfus Med Hemother 2016;43:169-176
   
  LOW-DOSE IRRADIATION PRIOR TO BONE MARROW TRANSPLANTATION RESULTS IN ATM ACTIVATION AND INCREASED LETHALITY IN ATM-DEFICIENT MICE

J. Pietzner, B.M. Merscher, P.C. Baer, R.P. Duecker, O. Eickmeier, D. Fussbroich, P. Bader, D. Del Turco, R. Henschler, S. Zielen, R. Schubert

Bone Marrow Transplant 2016;51:560-567
   
 

BIODISTRIBUTION, MIGRATION AND HOMING OF SISTEMICALLY APPLIED MESENCHYMAL STEM/STROMAL CELLS

J. Leibacher, R. Henschler

Stemm Cell Research and Therapy

2016; 7:7

   
2015

MOLEKULARE DIAGNOSTIK IN DER IMMUNHÄMATOLOGIE - WENN DIE SEROLOGIE NICHT MEHR AUSREICHT
F. Wagner, A. Döscher, C. Jungbauer, S. Lejon Crottet, A. Reil, C. Weinstock, C. Gassner, P. Bugert, C. Geisen

Hämotherapie (DRK Blutspendedienste)

2015, 25, p.4-21

   
 

PARALLEL DONOR GENOTYPING FOR 46 SELECTED BLOOD GROUP AND 4 HUMAN PLATELET ANTIGENS USING HIGH-THROUGHPUT MALDI-TOF MASS SPECTROMETRY

St. Meyer, N. Trost, B.M. Frey, C. Gassner

Humana Press

2015, ISSN 1064-3745

   
 

TTP/HUS AS AN INITIAL MANIFESTATION OF HIV INFECTION

P. Lodemann, B.M. Frey, D. Peetz, M. Bieringer

48. Jahreskongress DGTI 2015

15.-18. September 2015

Basel

   
 

ERYTHROZYTENKONZENTRATE AUS STAMMZELLEN

R. Henschler, B.M. Frey

Hämotherapie (DRK Blutspendedienste)

2015, 25, p.37-45

   
 

CALL OF DUTY: THE EFFECTS OF PHONE CALLS ON BLOOD DONOR MOTIVATION (incl. Supporting Information)

A. Bruhin, L. Goette, A. Roethlisberger, A. Markovic, R. Buchli, B.M. Frey

Transfusion

2015

doi:10.1111/trf.13236

   
 

FIRST DETAILED MOLECULAR CHARACTERIZATION OF A YUS (GE*01.-02) ALLELE AND DESCRIPTION OF A NOVEL GERBICH (GE*01.-03) ALLELE RESPONSIBLE FOR RARE PHENOTYPES IN THE GERBICH BLOOD GROUP SYSTEM

E. Gourri, E. Scharberg, T. Peyrard, B.M. Frey, C. Gassner

Vox Sang.,

Volume 109, Issue Supplement 1,

page 59, June 2015

   
 

RELIABLE DETECTION OF DUFFY X (FYx) - A WEAK VARIANT OF DUFFY B (FYB) BY A NEW REAGENT USING LATERAL FLOW TECHNIQUE 

S. Meyer, A. Caesar, N. Trost, K. Neuenschwander, B.M. Frey, C. Gassner, P. Schwind

Vox Sang.,

Volume 109, Issue Supplement 1,

pages 251-252, June 2015

   
 

MALDI-TOF MS FOR MNS TYPING - HIGH PHENO/GENOTYPE CONCORDANCE IN 5,743 SWISS

S. Meyer, C. Vollmert, N. Trost, J. Gottschalk, J. Ries, A. Markovic, L. Infanti, A.Buser, S. El Dusouqui, D. Castelli, T. Weingand, A. Sarraj, M.C. Braisch, J.Thierbach, B.M. Frey, C. Gassner

Vox Sang.,

Volume 109, Issue Supplement 1,

page 279, June 2015
   
 

MULTI-ETHNIC LEWIS PHENOTYPE PREDICTION USING PCR-SSP GENOTYPING ON FUT2 AND FUT3

S. Meyer, K. Neuenschwander, L. Castilho, B.M. Frey, C. Gassner

Vox Sang.,

Volume 109, Issue Supplement 1,

page 289, June 2015

   
 

COMPARISON OF TWO CAPILLARY HAEMOGLOBIN-MEASUREMENT SYSTEMS WITH A VENOUS GOLD STANDARD

G. Schorer, A. Markovic, E. Meyer, D. Goslings, B.M. Frey

Clin.Lab.

2015;61;S1-9,Poster 1

   
 

MALDI-TOF MS UND GENOMIK IN DER TRANSFUSIONSPRAXIS

C. Gassner, S. Meyer, C. Vollmert, B.M. Frey

Pipette-Swiss Laboratory Medicine

2/2015

   
 

NEURODEGENERATION IN THE ELDERLY - WHEN THE BLOOD TYPE MATTERS: AN OVERVIEW OF THE MCLEOD SYNDROME WITH FOCUS ON HEMATOLOGICAL FEATURES

B.M. Frey, C. Gassner, H.H. Jung

Transfusion and Apheresis Science

2015; 52:277-284

   
 

IMPACT OF RECIPIENT ABH SECRETOR STATUS ON OUTCOME IN MINOR ABO-INCOMPATIBLE HEMATOPOIETIC STEM CELL TRANSPLANTATION

A. Holbro, M. Stern, L. Infanti, A. O'Meara, B. Drexler, B.M. Frey, J.M. Tiercy, J.R. Passweg, C. Gassner, A. Buser, J.P. Sigle

Transfusion.

2015 Jan;55(1):64-9

   
2014

RHD VARIANTS IN FLANDERS, BELGIUM

V.S. Van Sandt , C. Gassner, M.P. Emonds, T.J. Legler, S. Mahieu,

G.F. Körmöczi

Transfusion.

2014 Nov 21.

[Epub ahead of print]

   
 

RESPONDER INDIVIDUALITY IN RED BLOOD CELL ALLOIMMUNIZATION

C. Gassner

Trans Med Hemother

2014 Nov;41(6):403-4

   
 

FUT2 AND FUT3 PCR-SSP FOR MULTI-ETHNIC LEWIS PHENOTYPE PREDICTION

S. Meyer, K. Neuenschwander, B.M. Frey, C. Gassner

Clin.Lab.

8/2014;60:S4/Nr. 7

   
 

DATA COLLECTION AND DATA SHARING - THE HOLY GRAL OF TRANSFUSION MEDICINE AND MODERN BIOSCIENCE

B.M. Frey, G. Fischer

Trans Med Hemother

2014 Oct; 41(5):336-337

   
 

HEMO ID - A ROBUST AND FLEXIBLE PANEL FOR BLOOD GROUP GENOTYPING, AND PREDICTED GENOTYPING

C. Vollmert, M. Sykes, B. Oelze, M. Dyrvold, B. Stierand-Peterwitz, S. Meyer, N. Trost, B.M. Frey, C. Gassner, K. Duvefelt, B. Just, A. Nygren

TransMed 2014

24, suppl.2, 33-75

   
 

IN HOUSE VALIDATION AND FIRST EXPERIENCE USING THE COBAS® TAQSCREEN MPX TEST, V2.0 FOR NAT SCREENING

A. Glauser, K. Hardegger, J. Gottschalk, B.M. Frey

Clin.Lab.

8/2014;60:S2/Nr. 2

   
 

PREVALENCE OF HEPATITIS B AND C VIRUS IN FIRST TIME BLOOD DONORS FROM ZURICH

Y.L. Song, J. Gottschalk, A. Röthlisberger, B.M. Frey

Clin.Lab.

8/2014;60:S1/Nr. 1

   
 

STATUS REPORT: LOOKBACK ON TRANSFUSED PRODUCTS OF A T. CRUZI-POSITIVE BLOOD DONOR

A. Markovic, J. Ries, J. Gottschalk, A. Glauser, B.M. Frey

Clin.Lab.

8/2014;60:S6/Nr. 9

   
 

ADVERSE REACTIONS IN APHERESIS DONORS: A 10 YEAR RETROSPECTIVE ANALYSIS AT ZHBSD

F.M. Martinez Leanes, A. Markovic, A. Glauser, J. Ries, B.M. Frey

Clin.Lab.

8/2014;60:S5/Nr. 8

   
 

BLACK AFRICAN VS+ ANTIGEN IS DEFINED BY C733 AND MAY CROSS-REACT WITH RHCE*E/e GENOTYPE

S. Meyer, N. Trost, C. Vollmert, J. Gottschalk, B.M. Frey, C. Gassner

Clin.Lab.

8/2014;60:S4/Nr. 6

   
 

ASSESSMENT OF D-NEGATIVE BLOOD SUPPLY FOR RHD*DAU-POSITIVE INDIVIDUALS

S. Meyer, C. Portmann, B.M. Frey, C. Gassner

Clin.Lab.

8/2014;60:S3/Nr. 5

   
 

ESTIMATED NEED FOR D NEGATIVE BLOOD WHEN TRANSFUSING RHD*DAU-POSITIVE INDIVIDUALS

S. Meyer, C. Portmann, B.M. Frey, C. Gassner

Vox Sang.,

Volume 107, Issue Supplement s1,

pages 57-248, P-422, June 2014

   
 

HIGH-THROUGHPUT KELL, KIDD, AND DUFFY MATRIX-ASSISTED LASER DESORPTION/IONIZATION, TIME-OF-FLIGHT MASS SPECTROMETRY-BASED BLOOD GROUP GENOTYPING OF 4000 DONORS SHOWS CLOSE TO FULL CONCORDANCE WITH SEROTYPING AND DETECTS NEW ALLELES

S. Meyer, C. Vollmert, N. Trost, C. Brönnimann, J. Gottschalk, A.Buser, B.M. Frey, C. Gassner

Transfusion,

2014 Dec;54(12):3198-207

 

   
 

PHYSIOLOGY OF IRON METABOLISM

S. Waldvogel-Abramovski, G. Waeber, C. Gassner, A. Buser, B.M.Frey, B. Favrat, J. Tissot

Transfus Med Hemother

2014Jun;41(3):213-221

   
 

IMPLEMENTATION OF A MANDATORY DONOR RHD SCREENING IN SWITZERLAND

S. Crottet, C. Henny, S. Meyer, F. Still, M. Stolz, J. Gottschalk, K. Neuenschwander, B. Mansouri Taleghani, P. Gowland, B.M.Frey, S. Fontana, H. Hustinx, C. Niederhauser, C. Gassner

Transfusion and Apheresis Science

2014 Apr;50(2):169-74

 

   
 

MOLECULAR RHD SCREENING OR RhD NEGATIVE DONORS CAN REPLACE STANDARD SEROLOGICAL TESTING FOR RhD NEGATIVE DONORS 

P. Gowland, C. Gassner, H. Hustinx, M. Stolz, J. Gottschalk, J. Tissot, J. Thierbach, A. Maier, S. Sigurdardottir, F. Still, S. Fontana, B.M. Frey, C. Niederhauser

Transfusion and Apheresis Science

2014 Apr;50(2):163-8

 

   
2013

NOVEL RHD ALLELES WITH WEAK HEMMAGLUTINATION AND GENETIC EXON 9 DIVERSITY: WEAK D TYPES 45.1, 75, AND 76

C. Gassner, I. Utz, H. Schennach, A. Ramoni, H. Steiner, S. Scholz, U.Kreklau, GF. Körmöczi

Transfusion

2013 Nov.; 53: 2954-9

   
 

IRON AND TRANSFUSION MEDICINE

S. Waldvogel-Abramovski, G. Waeber, C. Gassner, A. Buser, B.M.Frey, B. Favrat, J. Tissot

Blood Rev. 2013 Nov;27(6):289-95

 

   
 

MULTIPLE RECURRENT MUTATIONS AT FOUR HUMAN Y-CHROMOSOMAL SINGLE NUCLEOTIDE POLYMORPHISM SITES IN A 37 B P SEQUENCE TRACT ON THE ARSDP1 PSEUDOGENE

H. Niederstätter, B. Berger, D. Erhart, S. Willuweit, M. Geppert, C. Gassner, H. Schennach, W. Parson, L. Roewer

Forensic Sci Int Genet. 2013 Dec;7(6):593-600

 

 

   
 

THE LIVER GRAFT AS TROJAN HORSE-MULTILINEAGE DONOR-DERIVED HEMATOPOIESIS AFTER LIVER TRANSPLANTATION: CASE REPORT

W. Mark, R. Ollinger, H. Rumpold, D. Wolf, D. Nachbaur, F. Aigner, C. Margreiter, C. Gassner, H. Schennach, I, Graziadei, W. Vogel, R. Margreiter, E. Gunsilius

Transplant Proc. 2013 Nov;45(9):3438-41
  
 

MALDI-TOF MS BASED BLOOD GROUP GENOTYPING - PROGRESS OF
AN ALTERNATIVE APPROACH

C. Gassner

BBTS, 31st Annual Conference

16.-18. Oktober 2013

Birmingham

   
 

MISSENSE MUTATION N487S AND P488S OF THE ERYTHROPOIETIN RECEPTOR ARE NOT ASSOCIATED WITH CONSTITUTIVELY ELEVATED HEMOGLOBIN CONCENTRATION IN BLOOD DONORS

C. Brönnimann, C. Gassner, B.M. Frey

DGHO, SGH, OeGHO Kongress 2013

18.-22. Oktober 2013

Wien

   
 

HIGH RESOLUTION MAPPING OF Y HAPLOGROUP G IN TYROL (AUSTRIA)

B. Berger, H. Niederstätter, D. Erhart, C. Gassner, H. Schennach, W. Parson

Forensic Sci Int Genet. 2013 Sep;7(5):529-36

 

   
 

MOTIVATING BLOOD DONORS THROUGH PHONE REMINDERS: EVIDENCE FROM A LONG-TERM RANDOMIZED EVALUATION

L. Goette, A. Bruhin, A. Markovic, A. Röthlisberger, R. Buchli, B.M. Frey

46. Jahreskongress DGTI 2013

24.-27. September 2013

Münster

   
 

VEL-NEGATIVE ALLELE FREQUENCY COMPARISON IN ONE AUSTRIAN AND THREE SWISS REGIONS FOR EFFICIENCY OPTIMIZATION OF DONOR SCREENING AND RECRUITMENT

C. Jungbauer, S. Sigurdardottir, S. Meyer, J. Gottschalk, T. Schulzki, T. Weingand, A. Maier, B.M. Frey, C. Gassner

46. Jahreskongress DGTI 2013

24.-27. September 2013, Münster

Transfusion.
2013 Nov;53
(11 Suppl 2):2954-9

   
 

ADSORPTION-ELUTION DEPENDENT CONFIRMATION OF RHD POSITIVITY EXPRESSED BY THE LARGE HYBRID-ALLELE RHD-CE(4-9)-D

S. Meyer, K. Neuenschwander, S. Sigurdardottir, J. Gottschalk, T. Schulzki, T. Weingand, A. Maier, B.M. Frey, C. Gassner

46. Jahreskongress DGTI 2013

24.-27. September 2013

Münster

   
 

NEW RHD ALLELES WITH WEAK HEMAGGLUTINATION AND GENETIC EXON 9 DIVERSITY: weak D TYPES 45.1, 75, AND 76.

C. Gassner, I. Utz, H. Schennach, A. Ramoni, H. Steiner, S. Scholz, U. Kreklau, G. F. Körmöczi

46. Jahreskongress DGTI 2013

24.-27. September 2013

Münster

 

   
 

VALIDATION OF INTERCEPT BLOOD SYSTEM FOR PLASMA AT THE BLOOD TRANSFUSION SERVICE ZURICH

D. Goslings, A. Valek, B.M. Frey

SVTM Jahreskongress 2013

5./6. September 2013

Genf

   
 

ADSORPTION-ELUTION DEPENDENT CONFIRMATION OF RHD POSITIVITY EXPRESSED BY THE LARGE HYBRID-ALLELE RHD-CE(4-9)-D

S. Meyer, K. Neuenschwander, S. Sigurdardottir, J. Gottschalk, T. Schulzki, T. Weingand, A. Maier, B.M. Frey, C. Gassner

SVTM Jahreskongress 2013

5./6. September 2013

Genf

   
 

NEW RHD ALLELES WITH WEAK HEMAGGLUTINATION AND GENETIC EXON 9 DIVERSITY: weak D TYPES 45.1, 75, AND 76

C. Gassner, I. Utz, H. Schennach, A. Ramoni, H. Steiner, S. Scholz, U. Kreklau, G.F. Körmöczi

SVTM Jahreskongress 2013

5./6. September 2013

Genf

   
 

VEL-NEGATIVE ALLELE FREQUENCY COMPARISON IN ONE AUSTRIAN AND THREE SWISS REGIONS FOR EFFICIENCY OPTIMIZATION OF DONOR SCREENING AND RECRUITMENT

C. Jungbauer, S. Sigurdardottir, S. Meyer, J. Gottschalk, T. Schulzki, T. Weingand, A. Maier, B.M. Frey, C. Gassner

SVTM Jahreskongress 2013

5./6. September 2013

Genf

   
 

VALIDATION OF KEL (Kell), SLC14A1 (Kidd) AND DARC (Duffy) MALDI-TOF MS HIGH-THROUGHPUT BLOOD GROUP GENOTYPING USING >3.100 SEROLOGICALLY PRE-TYPED DONOR SAMPLES

S. Meyer, C. Vollmert, N. Trost, A. Buser, B.M. Frey, C. Gassner

SVTM Jahreskongress 2013

5./6. September 2013

Genf

   
 

SEROPREVALENCE OF HEPATITIS E VIRUS IN SWISS BLOOD DONORS ORIGINATING FROM THE CANTON OF ZURICH

J. Gottschalk, K. Hardegger, R. Darnuzer, B.M. Frey

SGM-Jahrestagung 2013

26./27. Juni 2013

Interlaken

 
   
 

VALIDATION OF KEL (KELL), SLC14A1 (KIDD) and DARC (DUFFY) MALDI-TOF MS HIGH THROUGHPUT BLOOD GROUP GENOTYPING USING >3.100 SEROLOGICALLY PRE-TYPED DONOR SAMPLES

S. Meyer, C. Vollmert, N. Trost, A. Buser, B.M. Frey, C. Gassner

23rd Regional Congress of the ISBT

3 - 5 June 2013

Amsterdam

 
   
 

MATRIX-ASSISTED LASER DESORPTION/IONISATION, TIME-OF-FLIGHT MASS SPECTROMETRY-BASED BLOOD GROUP GENOTYPING - THE ALTERNATIVE APPROACH

C. Gassner, S. Meyer, B.M. Frey, C. Vollmert

Transfusion Medicine Reviews 27 (2013) 2-9.  
   
2012

AGING AND CLEARANCE OF ERYTHROCYTES

C. Gassner

Transfus Med Hemother. 2012 Oct;39(5):297-8.  
   
 

A RARE KEL*02.17 / KEL*02N.06(IVS3+1g>a) COMPOUND HETEROZYGOUS INDIVIDUAL, PRONE TO ANTI-KEL11 IMMUNIZATION

S. Meyer, S. Sigurdardottir, C. Engström, A. Zorbas-Nikos, B.M. Frey, C. Gassner

45. Jahreskongress DGTI

11.-14. Sep. 2012

Graz

 
   
 

HÄUFIGKEIT UND VERLAUF VON ANTI-HLA KLASSE I UND KLASSE II ANTIKÖRPERN BEI 1552 THROMBOZYTAPHERESE-SPENDERN

E. Meyer, C. Brönnimann, Y. Merki, C. Gassner, B.M. Freyr

45. Jahreskongress DGTI

11.-14. Sep. 2012

Graz

 
   
 

MEASURES TO PREVENT TRANSFUSION-RELATED ACUTE LUNG INJURY (TRALI)H.W. Reesink, J. Lee, A. Keller, P. Dennington, J. Pink, R. Holdsworth, H. Schennach, M. Goldman, T. Petraszko, J. Sun, Y. Meng, K. Qian, V. Rehacek, ^P. Turek, T. Krusius, E. Juvonen, P. Tiberghien, D. Legrand, G. Semana, J.Y. Muller, J. Bux, A. Reil, C.K. Lin, H. Daly, E. McSweeney, L. Porretti, N. Greppi, P. Rebulla, H. Okazaki, S.A. Sanchez-Guerrero, H.A. Baptista-Gonzales, C. Martinez-Murillo, A. Guerra-Marquez, H. Rodriguez-Moyado, R.A. Middelburg, J.C. Wiersum-Osselton, A. Brand, C. van Tilburg, D. Dinesh, J. Dagger, P. Dunn, E. Brojer, M. Letowska, K. Maslanka, E. Lachert, M. Uhrynowska, E. Zhiburt, M. Palfi, G. Berlin, B.M. Frey, L. Puig Rovira, E. Muniz-Diaz, E. Castro, C. Chapman, A. Green, E. Massey, N. Win, L. Williamson, C.C. Silliman, D.J. Chaffin, D.R. Ambruso, N. Blumberg, P. Tomasulo, K.J. Land, P.J. Norris, O.C. Illoh, R.J. Davey, R.J. Benjamin, A.F. Eder, L. McLaughlin, S. Kleinman, S. Panzer 

Vox Sanguinis (2012) 103, 231-259  
   
 

PRESENCE OF DEL261G (O1) AND 803C (B) ON ONE HYBRID ALLELE - A POTENTIAL CAUSE FOR MISINTERPRETATION OF PCR-SSP RESULTS

S. Meyer, S. Sigurdardottir, K. Neuenschwander, B.M. Frey, C. Gassner

SVTM Jahreskongress 2012

6.-7. Sep. 2012

Basel

 
   
 

APPLICATION OF STATISTICAL PROCESS CONTROL (SPC) IN QUALITY CONTROL MONITORING OF BLOOD PRODUCTS

A. Glauser, E. Meyer, B.M. Frey

SVTM Jahreskongress 2012

6.-7. Sep. 2012

Basel

 
   
 

WHOLE BLOOD FILTER RZ-2000 EFFICIENTLY LEUKODEPLETES POOLED PLASMA PRIOR TO PATHOGEN INACTIVATION WITH INTERCEPT

D. Goslings, A. Valek, B.M. Frey

22nd Regional Congress of the ISBT

9-12 July, 2012

Cancun

 
   
 

A NAT ONLY HBV POSITIVE DONATION: BREAKTHROUGH SUBCLINICAL INFECTION IN A HBV VACCINATED BLOOD DONOR

J. Gottschalk, A. Glauser, K. Hardegger, B.M. Frey

22nd Regional Congress of the ISBT

9-12 July, 2012

Cancun

 
   
 

MCLEOD NEUROACANTHOCYTOSIS SYNDROME

H.J. Jung, A. Danek, R.H. Walker, B.M. Frey, C. Gassner

NCBI Bookshelf

last update May 17, 2012

https://www.ncbi.nlm.nih.gov/books/NBK1354/

 

 

   
2011

REPORT ON A HIGH-THROUGHPUT BLOOD GROUP GENOTYPING PROTOTYPE USING MATRIX-ASSISTED LASER DESORPTION/IONIZATION  TIME-OF-FLIGHT MASS SPECTROMETRY (MALDI-TOF MS)

C. Gassner, B.M. Frey, C. Vollmer

Transfusion

2011-Vol. 51, Supplement

 

   
 

DNA-ALIGNMENT DRIVEN JAK2 EXON 12 MUTATION ANALYSIS DEFINES 2 BROAD GENETIC MUTANT "CLUSTERS" AND SIMPLIFIES GENETIC TESTING BY PCR-SSP

C. Gassner, S. Sigurdardottir, E. Meyer, B.M. Frey

44. Jahreskongress DGTI

27.-30. Sep. 2011

Hannover

   
 

FLEXIBLE ORGANIZATION OF THE INTERCEPT PATHOGEN INACTIVATION PROCESS FOR PLATELETS OMITS EXTENSION OF PRODUCT SHELF-LIFE

A. Valek, D. Goslings, A. Röthlisberger, G. Yavuzcan, B.M. Frey

44. Jahreskongress DGTI

27.-30. Sep. 2011

Hannover

   
 

DISSECTION OF THE X-CHROMOSOMAL MCLEOD LOCUS AND DIRECT GENE SEQUENCING AS TOOLS FOR THE ANALYSIS OF KX GENE DELETIONS AND MUTATIONS

E. Meyer, M. Fragnière, C. Brönnimann, B.M. Frey, C. Gassner

44. Jahreskongress DGTI

27.-30. Sep. 2011

Hannover

   
 

A RARE KEL17/KEL(IVS3+1G>A) COMPOUND HETEROZYGOUS INDIVIDUAL, PRONE TO ANTIKEL11 IMMUNIZATION

S. Sigurdardottir, C. Engström, A. Zorbas-Nikos, B.M. Frey, C. Gassner

SVTM Jahreskongress

8.-9. Sep. 2011

Fribourg

   
 

PROGRESS REPORT ON A MALDI-TOF MASS SPECTROMETRY HIGH-THROUGHPUT BLOOD GROUP GENOTYPING PLATFORM

C. Gassner, B.M. Frey, C. Vollmer

SVTM Jahreskongress

8.-9. Sep. 2011

Fribourg

   
 

A NAT-ONLY HBV POSITIVE DONATION: BREAKTHROUGH SUBCLINICAL INFECTION IN A HBV VACCINATED BLOOD DONOR?

A. Glauser, J. Gottschalk, K. Hardegger, B.M. Frey

SVTM Jahreskongress

8.-9. Sep. 2011

Fribourg

   
 

HIGH-THROUGHPUT BLOOD GROUP GENOTYPING BY MATRIX-ASSISTED LASER DESORPTION/IONIZATION TIME-OF-FLIGHT MASS SPECTROMETRY (MALDI-TOF MS), REPORT ON A PROTOTYPE

C. Gassner, B.M. Frey, C. Vollmert

21st Regional Congress of the ISBT

18-22 June, 2011

Lisbon

   
 

INVESTIGATION OF BACTERIAL AND VIRAL AGENTS AND IMMUNE STATUS IN BEHCET'S DISEASE PATIENTS FROM IRAN

EU Irschick, S. Philipp, F. Shahram, M. Schirmer, M. Sedigh, N. Ziaee, C. Gassner, H. Schennach, M. Meyer, C. Larcher, M. Herold, D. Schoenitzer, D. Fuchs, M. Schoenbauer, M. Maass, HP. Huemer, F. Davatchi

Int. J. of Rheumatic Diseases

Vol. 14, Issue 3, 298-310

2011

   
 

EXTENSION OF UPPER AGE LIMIT FOR BLOOD DONATION IS SAFE AND HELPS TO SATISFY THE GROWING NEEDS FOR BLOOD PRODUCTS

D. Sinovcic, P. Lodemann, C. Engström, G. Yavuzcan, A. Röthlisberger, B.M. Frey

21st Regional Congress of the ISBT

18-22 June, 2011

Lisbon

   
 

VALIDATION AND IMPLEMENTATION OF THE INTERCEPT BLOOD SYSTEM FOR PLATELETS FOR PATHOGEN INACTIVATION OF APHERESIS AND BUFFY-COAT PRODUCTS AT ONE OF THE BIGGEST REGIONAL BLOOD-CENTERS OF SWITZERLAND

D. Goslings, P. Lodemann, G. Yavuzcan, A. Glauser, A. Valek, B.M. Frey

21st Regional Congress of the ISBT

18-22 June, 2011

Lisbon

   
 

FIRST VALIDATION AND IMPLEMENTATION OF THE ORBISAC SYSTEM IN A SWISS BLOOD-CENTER WITHIN THE SCOPE OF INTRODUCINGTHE PATHOGEN INACTIVATION SYSTEM INTERCEPT 

D. Goslings, A. Valek, B.M. Frey

 

21st Regional Congress of the ISBT

18-22 June, 2011

Lisbon

Poster

   
 

ADVERSE REACTIONS AFTER BLOOD DONATION - RISK PROFILE WITH SPECIAL EMPHASIS ON ELDERLY BLOOD DONORS

C. Engström, A. Röthlisberger, B.M. Frey

Swiss Medical Forum

Supplement 55

2011;11(18)

Poster

   
 

DNA-ALIGNEMENT DRIVEN JAK2 EXON 12 MUTATION ANAYSIS DEFINES 2 BROAD GENETIC MUTANT-"CLUSTER"-VARIANTS AND SIMPLIFIES GENETIC TESTING APPLYING PCR-SSP*

S. Sigurdardottir, C. Gassner, E. Meyer, B.M. Frey

*Dieser Beitrag wurde von der Schweiz. Gesellschaft für Hämatologie als bestes Abstract 2011 ausgezeichnet.

64. Jahrestagung SGH

11.-13.5.2011

Lausanne

   
 

EXPRESSION OF BLOOD GROUP GENES BY MESENCHYMAL STEM CELLS
R. Schäfer, M. Schnaidt, R.A. Klaffschenkel, G. Siegel, M. Schüle, M.A. Rädlein, U. Hermanutz-Klein, M. Ayturan, M. Buadze, C. Gassner, L. Danielyan, T. Kluba, H. Northoff and W.A. Flegel

British Journal of Haematology,

10.1111/j. 1365-2141

February 2011

   
2010

PROSPECTIVE COMPARISON OF EFFICACY OF THERAPEUTIC APHERESIS VERSUS CONVENTIONAL PHLEBOTOMY - PRELIMINARY DATA FROM HEMOCHROMATOSIS PATIENTS
P. Lodemann, J. Ries, G. Schorer, B.M. Frey

Transfusion and Apheresis Science, Vol. 43, Suppl. 1, S25, September 2010
   
 

SEROLOGY HELPS MOLECULARDIAGNOSTICS TO SOLVE A RARE CASE OF HOMOZYGOUS FY*X/FY*X - CONSEQUENCES FOR TRANSFUSION RECOMMENDATIONS
C. Engström, B. Grossrieder, C. Gassner, B.M. Frey

Transfusion and Apheresis Science, Vol. 43, Suppl. 1, S12, September 2010

 

 

   
 

FIRST CASE OF HIV WINDOW DONATION IN SWITZERLAND AFTER 8 YEARS OF UNIVERSAL HIV NAT SCREENING
J. Gottschalk, Y. Achermann, C. Niederhauser, C. Tinguely, A. Glauser, P. Lodemann, B.M. Frey

Transfusion and Apheresis Science, Vol. 43, Suppl. 1, S25, September 2010

Poster

   
 

COMPLEMENT AS AN ENDOGENOUS ADJUVANT FOR DENDRITIC CELL-MEDIATED INDUCTION OF RETROVIRUS-SPECIFIC CTLS
Zoltan Banki, Wilfried Posch, Asim Ejaz, Verena Oberhauser, Suzanne Willey, Christoph Gassner*, Heribert Stoiber, Ulf Dittmer, Manfred P. Dierich, Kim J. Hasenkrug, Doris Wilflingseder

* seit 1/4/2010 bei Blutspende Zürich

PLoS Pathogens, Vol. 6, Issue 4, April 2010

 

   
 

MULTICENTER STUDY OF THE NEW HIGHLY SENSITIVE AND SPECIFIC ENZYGNOST HBSAG 6.0 ASSAY
U. Schobel, T. Dengler, HW. Doerr, JM. Echevarria, WH. Gerlich, J. Gottschalk, M. Graziani, A. Karl, V. Schottstedt, F. Wagner, B. Weber, M. Weik, B. Weissbrich, WR. Willems, S. Nick

Vox Sanguinis

Vol. 99, Suppl. 1, July 2010

Abstract

   
 

IRON DEPLETION DYNAMICS AND SAFETY OF THERAPEUTIC ERYTHROCYTAPHERESIS VERSUS CONVENTIONAL PHLEBOTOMY IN PATIENTS WITH HAEMOCHROMATOSIS
Peter Lodemann, Judith Ries, Georg Schorer, Beat M. Frey

Vox Sanguinis

Vol. 99, Suppl. 1, July 2010

Poster

   
 

PROSOCIAL MOTIVATION AND BLOOD DONATIONS: A SURVEY OF THE EMPIRICAL LITERATURE
Lorenz Götte, Alois Stutzer, Beat M. Frey

Transfusion Medicine and Hemotherapy

Volume 37, Issue 3, June 2010

   
 

SAFEGUARDS IN BLOOD SUPPLY: A NATIONAL AND EUROPEAN CHALLENGE (EDITORIAL)
Beat M. Frey, Peter Schlenke

Transfusion Medicine and Hemotherapy

Volume 37, Issue 3, June 2010

 

   
 

ERHÖHTE INZIDENZ MALIGNER HÄMATOLOGISCHER ERKRANKUNGEN BEI BLUTSPENDERN MIT POSITIVEM DIREKTEN ANTIGLOBULINTEST (DAT)
Antje Enekwe, Jutta Theirbach, Barbara Ziegler, Beat M. Frey

Swiss Medical Forum

Supplementum 50

2010;10(18)
Poster

   
 

ANTI-HLA/PA-ANTIBODIES IN FEMALE BLOOD DONORS DEPEND ON GRAVIDITY STATUS AND REMAIN LIFE-LONG
B.M. Frey, Barbara Grossrieder, Antigony Nikos and Peter Lodemann

Swiss Medical Forum

Supplementum 50

2010;10(18)

   
 

FORTSCHRITTE IN DER HÄMATOLOGIE
B.M. Frey, Urs Nydegger

Pipette

Nr. 1, 10-11, 2010

   
2009

IRON BALANCE IN REPEAT BLOOD DONORS - THE ROLE OF HEPCIDIN
G. Schorer, G. Brittenham, R. Darnuzer, M. Westerman, B.M. Frey

Transfusion Medicine and Hemotherapy

Vol. 36, Suppl. 1, P 3.05, September 2009

Poster

   
 

ASSOCIATION OF X-LINKED CHRONIC GRANULOMATOUS DISEASE WITH THE RARE MCLEOD PHENOTYPE - A CASE REPORT
A. Siderow, J. Ries, B. Grossrieder, J. Reichenbach, R. Seger, M. Hergersberg, B. Röthlisberger, B.M. Frey

Transfusion Medicine and Hemotherapy

Vol. 36, Suppl. 1, P 1.16

September 2009

Poster

   
 

FIVE PARAMETER NAT SCREENING BY TAQSCREEN MPX WITH COBAS S201 IN SWITZERLAND: VALIDATION, IMPLEMENTATION AND FIRST EXPERIENCES

A. Glauser, K. Hardegger, J. Gottschalk, Beat M. Frey

Transfusion Medicine and Hemotherapy

Vol. 36, Suppl. 1, P. 10.04

September 2009

Poster

   
 

WRONG MOLAR HEMOGLOBIN REFERENCE VALUES - A LONGSTANDING ERROR THAT SHOULD BE CORRECTED
Peter Lodemann, Georg Schorer, Beat M. Frey

Annals of Hematology: Volume 89, Issue 2 (2010), Page 209

   
 

A PAIR OF NATURALLY OCCURRING ANTIBODIES MAY DAMPEN COMPLEMENT-DEPENDENT PHAGOCYTOSIS OF RED CELLS WITH A POSITIVE ANTIGLOBULIN TEST IN HEALTHY BLOOD DONORS
V. Alaia, B.M. Frey, A. Siderow, P. Stammler, M. Kradolfer and H.U. Lutz

Vox Sanguinis (2009) 97, 338-347

 

   
 

MCLEOD PHENOTYPE ASSOCIATED WITH X-LINKED CHRONIC GRANULOMATOUS DISEASE: A LIAISON WITH SERIOUS CONSEQUENCES
A. Siderow, J. Ries, B. Grossrieder, J. Reichenbach, R. Seger, M. Hergersberg and B.M. Frey

Swiss Medical Forum Supplementum 46, P162, 2009;9(18)

Poster (212 KB) 

   
  SEQUENTIAL BLOOD DONATION DECREASES TOTAL BODY IRON STORES AND SERUM HEPCIDIN
G. Schorer, G. Brittenham, R. Darnuzer, M. Westerman and B.M. Frey

 

Swiss Medical Forum

Supplementum 46, P177, 2009;9(18)

Poster (535 KB) 

   
  FOUR PARAMETER NAT SCREENING BY TAQSCREEN MPX WITH COBAS S201 IN SWITZERLAND: VALIDATION, IMPLEMENTATION AND FIRST EXPERIENCES
A. Glauser, K. Hardegger, J. Gottschalk and Beat M. Frey

Vox Sanguinis Vol. 96, Suppl. 1, P-111, April 2009

Poster (PDF 53 KB)

   
  FREE CHOLESTEROL TESTING AS A MOTIVATION DEVICE IN BLOOD DONATIONS: EVIDENCE FROM FIELD EXPERIMENTS
Lorenzo Goette, Alois Stutzer, Gürcan Yavuzcan and Beat M. Frey

TRANSFUSION, March 2009, Vol. 49, 524-531

 

   
2008  CHARACTERIZATION OF X-CHROMOSOMAL DELETIONS IN TWO PATIENTS WITH MCLEOD SYNDROME BY ARRAY COMPARATIVE GENOMIC HYBRIDIZATION (CGH)
M. Hergersberg, C. Ottiger, B.M. Frey, H.H. Jung, J. Reichenbach, R. Seger, B. Udd, J. Bruni, A.R. Huber, B. Röthlisberger
Swiss MedLab, Int. Congress, Montreux, September 16-19, 2008

Poster (PDF 166 KB)
   
  CHARACTERIZATION OF A 1.7 Mb X-CHROMOSOMAL DELETION IN A PATIENT WITH MCLEOD SYNDROME BY ARRAY CGH
M. Hergersberg, B. Röthlisberger, C. Ottiger, B.M. Frey, H.H. Jung, B. Udd, A.R. Huber
19. Jahrestagung der Deutschen Gesellschaft für Humangenetik, 2008

Poster (PDF 166 KB)
   
2007 SEIZURES OF EXTRATEMPORAL ORIGIN AS A PROMINENT FEATURE IN A TAMILIAN MALE WITH CHOREA-ACANTHOCYTOSIS
T. Dorn, B. Bader, A. Danek, H.H. Jung, Y. Achermann, B.M. Frey,
G. Krämer
27th Interntl Epilepsy Congress Proceedings.
Epilepsia 2007;48,suppl 7:p473

Poster (PDF 111 KB)
   
  MOLECULAR GENOTYPING OF ANTITHETIC KEL POLYMORPHISMS BY EXON-TARGETING PCR-RFLP
Beat M. Frey, Monika Furrer and Pascale Jaquet
Transfusion Medicine and Hemotherapy, Vol.34, Suppl 1, p73

Poster
(PDF 85 KB)
 
  BLOOD DONOR RECRUITMENT: EFFICACY OF VARIOUS INVITATION APPROACHES ON DONOR'S DECISION MAKING
O. Ochmann, A. Stutzer, G. Staeheli, L. Götte and B.M Frey
Transfusion Medicine and Hemotherapy, Vol.34, Suppl. 1, p73

Poster
(PDF 69 KB)
 
  MCLEOD SYNDROME - A NEURO-HEMATOLOGICAL DISORDER
Hans H. Jung, Adrian Danek and Beat M. Frey
Vox Sanguinis (2007) 93, 112-121

Paper (PDF 259 KB)
 
  IRON BALANCE IN YOUNG BLOOD DONORS: IS THE LATENT IRON DEFICIENCY SYNDROME (LIDS) UNIVERSAL?
Oswin Ochmann, Karin Hardegger and Beat M. Frey
Forum Med. Suisse
2007;7 (Suppl. 35), 73 S

Poster (PDF 67 KB)
 
  THE END OF A DIAGNOSTIC ODYSSEY – A CASE OF CHUVASH POLYCYTHEMIA
A. Rüfer, P. Jaquet, WA. Wuillemin and B.M. Frey
Forum Med. Suisse
2007;7 (Suppl. 35), 72 S

Poster (PDF 194 KB)
 
  IRON BALANCE REMAINS STABLE IN LIFE-LONG BLOOD DONORS
Beat M. Frey, Axel Rüfer, Karin Hardegger, Gabriela Bachmann, Christine Kuhn, Irène Schmid, Franziska Wägli and Oswin Ochmann
Forum Med. Suisse
2007;7 (Suppl. 35), 78 S

Poster (PDF 551 KB)
 
  PHENOTYPIC VARIABILITY OF A DISTINCT DELETION IN MCLEOD SYNDROME
Marcelo Miranda, Claudia Castiglioni, Beat M. Frey, Martin Hergersberg, Adrian Danek and Hans H. Jung
Mov Disord (2007); Vol.22, No.9: 1358-1361

 
 
  FREQUENT PLATELET APHERESIS DONATION IN VOLUNTEER DONORS
WITH HAEMOGLOBIN <125g/l ARE SAFE AND EFFICIENT

Adriana Méndez, Franziska Wägli, Irène Schmid and Beat M. Frey
Transfusion and Apheresis Science (2007) 36, 47-53

Paper (PDF 340 KB)
 
 
2006 ALLOCATION OF TRANSFUSION COMPATIBLE RED BLOOD CELL CONCENTRATES IN THE PRESENCE OF WARM-REACTIVE ANTIBODIES –
A RETROSPECTIVE COMPARISON OF TWO DIFFERENT STRATEGIES

Edi Matheis, Barbara Grossrieder, Anna E. Böhlen-Bodmer, Monika Furrer
and
Beat M. Frey
Transfusion Medicine and Hemotherapy 2006,
Vol. 33 (Suppl. 1), abstr. P6.13, S 46

Poster (PDF 45 KB)
 
  GENOTYPIC AND PHENOTYPIC CHARACTERIZATION OF DOMBROCK (Do) BLOOD GROUP ANTIGENS IN BLOOD DONORS
Inga Hegemann, Pascale Jaquet, Monika Furrer and Beat M. Frey
Transfusion Medicine and Hemotherapy 2006,
Vol. 33 (Suppl. 1), abstr. P6.15, S 46

Poster (PDF 151 KB)
 
  COOMBS-POSITIVE RED BLOOD CELLS IN HEALTHY BLOOD DONORS,
AN EVIDENCE-BASED EXPLANATION

Velia Alaia, Beat Frey, and Hans U. Lutz
Gemeinsame Jahrestagung der Deutschen,
Österreichischen und Schweizerischen
Gesellschaft für Hämatologie und Onkologie
Leipzig, 2006
 
  REMAINING RED BLOOD CELL ALLO-ANTIBODIES IN BLOOD PRODUCTS DONATED BY ALLO-SENSITIZED BLOOD DONORS. A COMPARATIVE TITRATION STUDY
Edi Matheis, Annelies Böhlen-Bodmer, Barbara Grossrieder and
Beat M. Frey
Forum Med Suisse
2006;6: (Suppl 30), 62 S

Poster (PDF 92 KB)
 
 
  D ANTIGEN DENSITY AND D ZYGOSITY OF REAGENT RED CELLS ARE NOT DETERMINANT FOR ANTI-D SEMIQUANTIFICATION BY STANDARD SEROLOGY TITRATION TECHNIQUES
B.M. Frey, N. Dogan, P. Jacquet, M. Furrer
Forum Med Suisse
2006;6: (Suppl 30), 63 S

Poster (PDF 28 KB) 
 
  PREVALENCE, SPECIFICITY AND TITER OF ALLO-ANTIBODIES IN VOLONTARY BLOOD DONATIONS AND IN THE CORRESPONDING BLOOD PRODUCTS
Beat M Frey, Edi Matheis, A. Böhlen-Bodmer, B. Grossrieder
Vox Sanguinis (2006) 91: Supp.3, P-424

Poster (PDF 99 KB)  
 
  TESTING FOR WEAK D - INTERNATIONAL FORUM
C.P. Engelfried, H.W. Reesink, G.F. Körmöczi, W.R. Mayr, S. Panzer,
D. Schönitzer, R. Fontao-Wendel, S. Wendel, A. Long, M.H. Dziegiel,
V. Kretschmer, R. Karger, F. Morelati, N. Revelli, M.A. Villa, M. Lai,
M. de Haas, E. van der Schoot, M. Overbeeke, P. Maaskant, D.Gounder,
P. Flanagan, G.B. Solheim, B. Zupanska, M. Lozano, B. Michalewska,
E. Muniz-Diaz, C. Martin-Vega, B.M. Frey, A. Mendez, S.A. Kochman,
J.S. Epstein, G. Garratty, C. Lomas-Francis, C.M. Westhoff
Vox Sanguinis (2006) 90: 140 - 153
 
2005

TRANSFUSION OF APHERESIS PLATELETS AND ABO GROUPS - INTERNATIONAL FORUM
R.N.I. Pietersz, C.P. Engelfried, H.W. Reesink, K.G. Davis, J. Lown,
A. Thomson, P. Turek, E. Dickmeiss, T. Krusius, J. Matilainen, V. Kretschmer, R. Karger, P. Reinhardt, M. Wiesneth, H. Schrezenmeier, E. Seifried,            P. Rebulla, N. Greppi, D. Riccardi, F. Molrelati, M. Uchikawa, N.H. Tsuno,       K. Takahashi, K. Tadokoro, V.M.J. Novotny, A. Brand, B.G. Solheim,            B. Zupanska, M. Lozano, J. Cid, R. Mazzara, F. Knutson, R. Norda, B.M. Frey, S. MacLennan, J.M. Heal, N. Blumberg

Vox Sanguinis (2005) 88: 2007 - 221
 
  SHOULD WE CHANGE OUR CURRENT PRACTICE OF BLOOD DONOR SCREENING IN SWITZERLAND? THE ALAT DATA

Axel Rüfer, Karin Bracher, Adrian Röthlisberger, Gürcan Yavuzcan and
Beat M. Frey  
Swiss Medical Forum,
Suppl. 23, 2005, May 11th, 69s, P200
 
  PREVALENCE AND SPECIFICITY OF BLOOD GROUP ANTIBODIES IN SWISS BLOOD DONORS

Edi Matheis, Annelies Böhlen-Bodmer, Karin Hardegger, Annette Schille and Beat M. Frey
Swiss Medical Forum,
Suppl. 23, 2005, May 11th, 70s, P205
 
  PREVALENCE AND GENOTYPE OF weakD RED BLOOD CELL PHENOTYPES IN SWISS BLOOD DONORS
Adriana Méndez, Pascale Jaquet, Karin Hardegger, Annette Schille, Monika Furrer and Beat M. Frey
Swiss Medical Forum,
Suppl. 23, 2005, May 11th, 70s, P204
 
  QUANTIFICATION OF D-ANTIGEN DENSITY OF weakD RED BLOOD CELL PHENOTYPES BY FLOWCYTOMETRY. A RAPID METHOD TO ESTIMATE THE ANTI-D IMMUNIZATION RISK
Adriana Méndez, Pascale Jaquet, Monika Furrer and Beat M. Frey
Swiss Medical Forum,
Suppl. 23, 2005, May 11th, 22s, abstr. S71
 
 

ASSIGNEMENT OF Lub-NEGATIVITY FOR RARE DONOR SELECTION REQUIRES SOPHISTICATED TECHNIQUES BASED ON MOLECULAR GENOTYPING

Christian Rüegg, Adriana Mendez, Edi Matheis, Annelies Böhlen-Bodmer and Beat M. Frey

Swiss Medical Forum,
Suppl. 23, 2005, May 11th, 22s, abstr. S72
 
  COLLECTION OF SINGLE DONOR PLATELET CONCENTRATES BY TRIMA ACCEL, COBE/SPECTRA AND AMICUS CRESCENDO DEVICES: A LARGE, PROSPECTIVE-RANDOMIZED, COMPARATIVE-CROSSOVER STUDY
Dagmar Matz, Fränzi Wägli, Ulrike Murer, Monika Furrer and Beat M. Frey
Swiss Medical Forum,
Suppl. 23, 2005, May 11th, 71s, P207
 
2004 SIGNIFICANCE OF CONFIRMATORY TESTING OF BLOOD DONORS WITH POSITIVE SCREENING FINDINGS FOR ANTI-HIV AND ANTI-HCV
A. Mendez, A. Rüfer and B.M Frey
Swiss Medical Forum,
Suppl 17, 2004; 4: S36, abstr. 239
 
 
  UNIVERSAL LEUKODEPLETION OF BLOOD PRODUCTS IN SWITZERLAND: A RETROSPECTIVE ANALYSIS OF QUALITY ASSURANCE DATA
Beat M. Frey, E. Skalsky, M. Frey-Wettstein
Swiss Medical Forum,
Suppl 17, 2004; 4: S91, abstr. 536
 
  DIE ENTWICKLUNG DER TRANSFUSIONSMEDIZIN IN DER SCHWEIZ VOM ZWEITEN WELTKRIEG BIS 2003
M. Frey-Wettstein
Transfus Med Hemother 2004; 31(suppl 2): 86-94
 
2003 MCLEOD PHENOTYPE ASSOCIATED WITH A XK MISSENSE MUTATION WITHOUT HEMATOLOGICAL, NEUROMUSCULAR, or CEREBRAL INVOLVEMENT
H.H. Jung, M. Hergersberg, M. Vogt, J. Pahnke,
V. Treyer, S.S. Kollias, D.Russo, and B.M. Frey
Transfusion, 2003; Vol 43: 928-38
 
  ENUMERATION OF RESIDUAL CELLS IN LEUKODEPLETED BLOOD
PRODUCTS – TECHNIQUES AND PITFALLS

Beat M. Frey and Monika Furrer-Burger
in “Universal Leucodepletion: the European experience” by
U. Rossi and R.Garcia de Villaescusa
Edizioni SIMTI, Milano, 2003, pp. 105-116
 
  HISTORY OF BLOOD FILTRATION

Manuel Frey-Wettstein
in “Universal Leucodepletion: the European experience” by
U. Rossi and R.Garcia de Villaescusa
Edizioni SIMTI, Milano, 2003, pp. 3-8
 
  THE PRESENT SITUATION AND FUTURE DEVELOPMENTS OF UNIVERSAL LEUCODEPLETION IN EUROPE
Manuel Frey-Wettstein
in “UniversalL eucodepletion: the European experience” by
U. Rossi and R.Garcia de Villaescusa
Edizioni SIMTI, Milano, 2003, pp. 167-168
 
  CHRONIC PLATELET APHERESIS DONATION OF VOLUNTEER DONORS WITH HB <125 G/L IS SAVE AND EFFICIENT
Adriana Mendez, Beat M. Frey
Swiss Medical Forum,
Suppl 12, 2003, Mai 7,
70s, abstr. 432
 
  HCV-RNA SCREENING OF SWISS BLOOD DONORS IS REDUNDANT TO ESTABLISHED SURROGATE MARKER TESTING
Martin Siroky, Andreas Glauser, Sonja Rosamilia, Beat M. Frey
Swiss Medical Forum,
Suppl 12, 2003, Mai 7,
35s, abstr. 205
 
2002 REPRODUCIBLE QUANTIFICATION OF RESIDUAL WHITE BLOOD CELLS IN LEUKODEPLETED BLOOD PRODUCTS BY FLOWCYTOMETRY OVER MORE THAN 5 DAYS
Beat M. Frey, Monika Furrer, Manuel Frey-Wettstein
Swiss Medical Forum
Suppl 8, 2002, April 10, 64S, abstr. 344
 
  COOMBS-POSTIVE RED BLOOD CELLS OF HEALTHY BLOOD DONORS CARRY ANTI-C3/C3B NATURALLY OCCURRING ANTIBODIES (NAbs)
Violla Ankelmann1, Beat M. Frey1, M. Vogt1, Rita Eggmann2, Claudia Janda2, Ivan Galimberti2, Hans U. Lutz2
1Stiftung Zürcher Blutspendedienst SRK, 2Institute of Biochemistry, Swiss Federal Institute of Technology, ETH-Zentrum, 8092 Zürich
Swiss Medical Forum
Suppl 8, 2002, April 10, 64S, abstr. 342
 
  THE G1016A XK MISSENSE MUTATION CAUSES McLEOD IMMUNOPHENOTYPE WITHOUT SYSTEMIC INVOLVEMENT
B.M. Frey*, M. Furrer, M. Vogt, Regional Blood Transfusion Service SRC, Zürich; M. Hergersberg, Department of Molecular Biology, Cantonal Hospital, Aarau; V. Treyer, S. Kollias, H.H. Jung, University Hospital Zürich, Switzerland
27th Congress of the International Society of Blood Transfusion (ISBT), August 24 - 28, 2002, Vancouver, BC
 
2001 QUALITY CONTROL OF BLOOD COMPONENT PRODUCTS BY FLOWCYTOMETRY
Beat M. Frey, Monika Furrer, Manuel Frey-Wettstein
Swiss Medical Forum
Suppl 2, 2001, April 25, 71S, abstr. 345
 
  QUANTIFICATION OF RESIDUAL RED BLOOD CELLS IN PLATELET CONCENTRATES AND FRESH FROZEN PLASMA BY FLOWCYTOMETRY
Beat M. Frey, Ursina Minder, Monika Furrer,
Manuel Frey-Wettstein
Swiss Medical Forum
Suppl 2, 2001, April 25, 71S, abstr. 344
 
  LARGE VOLUME LEUCOCYTAPHERESIS FOR AUTOLOGOUS PROGENITOR CELL HARVESTING PERFORMED IN A MULTI-INSTITUTIONAL TRANSPLANTATION PROGRAM: FIRST RESULTS AND FUTURE DIRECTIONS
B.M. Frey1, A. Buser1, M. Frey-Wettstein1, A. Tobler2,
K. Zbären2, E. Ischi2, A. von Rohr3, Th. Von Briel3,
H. Gattiker4, V. Hofmann4, U. Breitenstein4, U. Huber4,
A. Messner4, J. Gmür4
1Stiftung Zürcher Blutspendedienst SRK, Zürich; 2Hämatologisches Zentrallabor, Inselspital, Bern; Onkozentrum 3Hirslanden und 4Klinik Im Park, Zürich
Swiss Medical Forum
Suppl 2, 2001, April 25, 64S, abstr. 319
 
2000 HCV-SCREENING VON BLUTSPENDEN MIT SIMULTANER PCR/ELISA TECHNIK ERMÖGLICHT "STATE-OF-THE-ART" SCREENING VON ALLEN ZUR TRANSFUSION FREIGEGEBENEN LABILEN UND STABILEN BLUTPRODUKTEN OHNE VERZÖGERUNG DER PRODUKTFREIGABE.
B.M. Frey1, G. Yavuzcan1, S. Rosamilia1, A. Glauser2, M. Frey-Wettstein1
1Stiftung Zürcher Blutspendedienst SRK,
Hirschengraben 60, CH-8001 Zürich/Switzerland
2Phoenix International (ANAWA), Wangen/Zürich
Schweiz Med Wochenschr, 2000;
130: Suppl 115: 44S
 
1999

TEMPERATURE CONTROL OF BLOOD COMPONENTS DURING TRANSPORTATION.

C. Fritsch, M. Frey-Wettstein, B.M. Frey

VI Regional European Congress of Blood Transfusion (ISBT), Jerusalem,
May 9-13, 1999
 
  SCREENING FOR HCV BY SIMULTANEOUS PCR-/ELISA TECHNIQUES: STATE-OF-THE-ART TESTING OF LABILE AND STABILE BLOOD PRODUCTS PRIOR TO TRANSFUSION.
B.M. Frey1, G. Yavuzcan1, S. Rosamilia1, A. Glauser2, M. Frey-Wettstein1
1Stiftung Zürcher Blutspendedienst SRK, Hirschengraben 60, CH-8001 Zürich/Switzerland
2Phoenix International (ANAWA), Wangen/Zürich
52nd Annual Meeting of the American
Association of Blood Banks (AABB),
San Francisco, Nov 6-10, 1999
 
  SINGLE DONOR PLATELET CONCENTRATES (SDPC) COLLECTED BY AMICUS, COBE/SPECTRA AND MCS3P APHERESIS DEVICES COMPLY VARIABLY WITH ECONOMICAL AND REGULATORY REQUIREMENTS FOR PRODUCTION OF HIGH QUALITY APHERESIS PRODUCTS.
B.M. Frey, S. Rosamilia, A. Buser, I. Schmid, M. Frey-Wettstein
52nd Annual Meeting of the American
Association of Blood Banks (AABB),
San Francisco, Nov 6-10, 1999
 
1998 SINGLE DONOR PLATELET CONCENTRATES (SDPC) COLLECTED FROM VOLUNTEER APHERESIS DONORS (VAD) IN AN ENVIRONMENT OF INCREASING ECONOMICAL AND REGULATORY PRESSURES - IMPACT ON THE BLOOD CENTER'S SUPPLY PROGRAM.
B.M. Frey, S. Rosamilia, A. Buser, I. Schmid and M. Frey-Wettstein 
Infusionsther Transfusionsmed 1998;
25(Suppl 1): 40
 
 

EFFIZIENTE TRANSGEN-ÜBERTRAGUNG IN HÄMATOPOIETISCHE VORLÄUFER- UND CD34+ STAMMZELLEN MITTELS NEUEM ADENOVEKTOR.

B.M. Frey1,4, S. Rafii2, R.G. Crystal3, und M.A.S. Moore1,
1Memorial Sloan-Kettering Cancer Center, 2Departement of Hematology/Oncology, 3Departement of Pulmonary and Critical Care Medicine, The New York Hospital/Cornell Medical Center, New York und 4Stiftung Zürcher Blutspendedienst SRK

Schweiz Med Wochenschr 1998;
128: Suppl 96, 63S
 
 

ADENOVIRALE LANGZEIT-EXPRESSION VON THROMBOPOIETIN IN VIVO: EIN NEUES MODELL FÜR MYELOPROLIFERATIVES SYNDROM UND OSTEOMYELOFIBROSE.*

B.M. Frey1,4, S. Rafii2, R.G. Crystal3, und M.A.S. Moore1
1Memorial Sloan-Kettering Cancer Center, 2Departement of Hematology/Oncology, 3Departement of Pulmonary and Critical Care Medicine, The New York Hospital/Cornell Medical Center, New York und 4Stiftung Zürcher Blutspendedienst SR

*Diese Beitrag wurde von der Schweiz. Gesellschaft für Hämatologie als bestes Abstract 1998 ausgezeichnet.

Schweiz Med Wochenschr 1998;
128: 1587-1592